Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps
United European Gastroenterology Journal · 2024
DOI: 10.1002/ueg2.12667 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Alejandro Martínez-Roca und 23 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Medicina Digestiva, Instituto de Investigación Sanitaria ISABIAL, Hospital General Universitario Dr. Balmis, Alicante, Spain. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Proto-Oncogene Proteins p21(ras), Mutation, Colonic Polyps. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Gonzalo Miño Grant Asociación Española de Gastroenterología 2016 and 2022, Fundación SEED Grant 2018.
Abstract (Originalsprache)
Background
The potential of molecular markers in the removed polys as reliable predictors of metachronous lesions is still uncertain.
Aim
Our aim was to evaluate the role of somatic mutations in KRAS in polyps of patients with high‐risk adenomas to predict the risk of advanced polyps or colorectal cancer (CRC) within 3 years.
Methods
A total of 518 patients were prospectively enrolled. The included patients had adenomas ≥10 mm, high‐grade dysplasia, villous component or ≥3 more adenomas at baseline and were scheduled to undergo surveillance colonoscopy at 3 years ± 6 months. Somatic KRAS mutation was performed on 1189 polyps collected from these patients. At surveillance, advanced lesions were defined as adenomas with a size of ≥10 mm. High‐grade dysplasia or villous component, serrated polyps ≥10 mm or with dysplasia or CRC.
Results
At baseline, 81 patients (15.6%) had KRAS mutations in at least one polyp. Patients with KRAS mutated polyps had more frequent villous histological lesions and size ≥20 mm. In the multivariate analysis, adjusted for age and sex, only age (odds ratios [OR], 1.06; 95% confidence interval [CI], 1.02–1.09; p < 0.001), ≥5 adenomas (OR, 3.92; 95% CI, 1.96–7.82), and KRAS mutation (OR, 2.54; 95% CI, 1.48–4.34; p < 0.01) were independently associated with the development of advanced lesions at surveillance.
Conclusions
Our results show that, in patients with high‐risk adenomas, the presence of somatic mutations in KRAS is an independent risk factor for the development of advanced metachronous polyps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Medicina Digestiva, Instituto de Investigación Sanitaria ISABIAL, Hospital General Universitario Dr. Balmis, Alicante, Spain.
- Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain.
- Department of Gastroenterology, Research Group in Gastrointestinal Oncology-Ourense, CIBEREHD, Hospital Universitario de Ourense, Ourense, Spain.
- Pathology Department, Alicante Institute for Health and Biomedical Research (ISABIAL), Dr. Balmis General University Hospital, Alicante, Spain.
- Clinical Pharmacology Department, Alicante Institute for Health and Biomedical Research (ISABIAL), Dr. Balmis General University Hospital, Alicante, Spain.
- Department of Pathology, Hospital Universitario de Ourense, Ourense, Spain.
ORCID-Profile: Alejandro Martínez-Roca, Joaquín Cubiella, Sandra Baile-Maxía, Monika Ferlitsch, Rodrigo Jover
Förderung
- Instituto de Salud Carlos III
- Gonzalo Miño Grant Asociación Española de Gastroenterología 2016 and 2022
- Fundación SEED Grant 2018
Zitieren
APA
Martínez-Roca, A., Cubiella, J., García-Heredia, A., Guill-Berbegal, D., Baile-Maxía, S., Mangas-Sanjuán, C., Sala-Miquel, N., Madero-Velazquez, L., Alenda, C., Zapater, P., González-Núñez, C., Iglesias-Gómez, A., Codesido-Prado, L., Díez-Martín, A., Kaminski, M. F., Erichsen, R., Adami, H. O., Ferlitsch, M., Pellisé, M., …, & EPoS Study Group (2024). Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12667
Vancouver
Martínez-Roca A, Cubiella J, García-Heredia A, Guill-Berbegal D, Baile-Maxía S, Mangas-Sanjuán C, et al. Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12667
BibTeX
@article{MartnezRoca2024,
author = {Martínez-Roca, Alejandro and Cubiella, Joaquín and García-Heredia, Anabel and Guill-Berbegal, David and Baile-Maxía, Sandra and Mangas-Sanjuán, Carolina and Sala-Miquel, Noelia and Madero-Velazquez, Lucía and Alenda, Cristina and Zapater, Pedro and González-Núñez, Clara and Iglesias-Gómez, Agueda and Codesido-Prado, Laura and Díez-Martín, Astrid and Kaminski, Michal F and Erichsen, Rune and Adami, Hans-Olov and Ferlitsch, Monika and Pellisé, María and Holme, Øyvind and Dekker, Evelien and Bretthauer, Michael and Jover, Rodrigo and EPoS Study Group, EPoS Study Group},
title = {Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps},
journal = {United European Gastroenterology Journal},
year = {2024},
doi = {10.1002/ueg2.12667}
}
EUVIMED